Explore groundbreaking research on pancreatic cancer treatment that shows promise in inducing complete tumour regression.

Combination therapies represent a promising frontier in cancer treatment, addressing the critical need to enhance efficacy ...

Early data from a Phase 2 clinical trial show a combination of immunotherapy medications can activate a robust immune response and help overcome treatment resistance in patients with refractory ...

A specific genetic alteration, known as an ALK fusion, drives non-small cell lung cancer in some patients. This abnormality leads to excessive activity of the ALK protein, a key cancer promoter. These ...

A research team at the Medical University of Vienna has discovered a new approach to treating a particularly frequent and difficult-to-treat form of lung cancer. The study shows that a combination of ...

The growing resistance of bacteria to existing antimicrobial drugs is a major problem, making it essential to find new ways to treat bacterial infections. Sometimes, antibiotics alone are not ...

Cancer treatment has made remarkable strides. New drugs and technologies have changed outcomes for many patients, turning some once-fatal diagnoses into manageable conditions. Yet despite these ...

The field of oncology has witnessed remarkable progress in the treatment of solid tumors, yet the quest for optimal therapeutic outcomes remains a formidable challenge. Current clinical evidence ...